Network origin in Bas Cohen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Vrije Universiteit Amsterdam
33
| College/University | Other Consumer Services | 33 |
Rivean Capital BV
 Rivean Capital BV Investment ManagersFinance Rivean Capital BV (Rivean Capital) is a private equity subsidiary of Rivean Capital Management Holding BV founded in 1982. The firm is headquartered in Amsterdam, the Netherlands.
33
| Subsidiary | Investment Managers | 33 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bas Cohen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Credit Suisse International
 Credit Suisse International Financial ConglomeratesFinance Credit Suisse International engages in the provision of financial products and services focused on client driven businesses. It operates through the following segments: Investment Bank, Capital Release Unit, and Corporate Centre. The company was founded on May 9, 1990 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Corporate Officer/Principal | |
Bridgepoint Advisers Ltd.
 Bridgepoint Advisers Ltd. Investment ManagersFinance Bridgepoint Advisers Ltd (Bridgepoint Advisers) is a private equity subsidiary of Bridgepoint Group Ltd. founded in 1984. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Analyst | |
Van Lanschot Kempen Investment Management NV
 Van Lanschot Kempen Investment Management NV Investment ManagersFinance Van Lanschot Kempen Investment Management NV (Van Lanschot Kempen) is a specialist wealth manager headquartered in Amsterdam, Netherlands. The firm was founded in 1991 and was formerly known as Kempen Capital Management NV. They are a wholly-owned subsidiary of Van Lanschot Kempen NV (AMS: VLK). Van Lanschot Kempen administers Dutch pension funds and provides integral asset management for Dutch institutional clients. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Fixed Income Portfolio Manager-Equities Portfolio Manager-Fixed Income | |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Private Equity Analyst Private Equity Investor | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
| Maastricht University | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Gimv Nederland BV
 Gimv Nederland BV Investment ManagersFinance Gimv Nederland BV (Gimv-Nederland) is the Netherlands-based private equity subsidiary of GIMV Corporate Investment, which in turn is a subsidiary of Gimv NV (XB: GIMB) in Belgium. Established in 1983, Gimv-Nederland was formerly known as Halder Invest BV and became part of the Gimv Group in 2000. The firm is located in The Hague with additional offices in Frankfurt and Antwerp. Their clients include fund of funds, insurance companies, banks, corporations and pension funds. | Investment Managers | Private Equity Analyst | |
| University of Tilburg | College/University | Undergraduate Degree | |
JPMorgan Cazenove Ltd.
 JPMorgan Cazenove Ltd. Investment Banks/BrokersFinance J.P. Morgan Cazenove Ltd. (JPMC) is jointly owned by JPMorgan and Cazenove Group Ltd. Headquartered in London, JPMC has offices in Hong Kong, Beijing, Singapore, Frankfurt, Paris and New York as well as access to JPMorgan's global network. The firm provides a full range of investment banking services, including financial advice, M&A, investor relations, debt and equity capital markets advice and execution and equity research and distribution. The Equities business forms an important part of the Investment Banking division. JPMC analysts cover the major stocks in all areas of specialisation across the UK, Europe and Asia ex-Japan | Investment Banks/Brokers | Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Twente | College/University | Graduate Degree Corporate Officer/Principal | |
| University of Amsterdam | College/University | Director/Board Member Undergraduate Degree Graduate Degree Graduate Degree | |
| Erasmus University Rotterdam | College/University | Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| Delft University of Technology | College/University | Graduate Degree Graduate Degree | |
| University of Groningen | College/University | Graduate Degree Graduate Degree | |
| Radboud University Nijmegen | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Holland Capital Management BV
 Holland Capital Management BV Investment ManagersFinance Holland Capital Management BV (Holland Capital) is an independent private equity & venture capital firm founded in 1981. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Public Communications Contact Private Equity Investor | |
Vitruvian Partners LLP
 Vitruvian Partners LLP Investment ManagersFinance Vitruvian Partners LLP (Vitruvian Partners) is a private equity firm founded in 2006 by Ian Riley, Michael Risman, Toby Wyles, Mark Harford and David Nahama. The firm is headquartered London, the United Kingdom with offices across the globe. | Investment Managers | Private Equity Investor | |
| Liaoning University | College/University | Graduate Degree | |
AAC Capital Partners Management BV
 AAC Capital Partners Management BV Investment ManagersFinance AAC Capital Partners Management BV is a Northern European mid-market buy-out firm established by the former Dutch, Nordic and UK buy-out teams of ABN AMRO Capital. AAC Capital Partners Management BV is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Analyst | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
| IVA Driebergen BV | College/University | Undergraduate Degree | |
| LATAM AIRLINES GROUP S.A. | Airlines | Director/Board Member | |
Mckinsey & Co. /Amsterdam/
 Mckinsey & Co. /Amsterdam/ Miscellaneous Commercial ServicesCommercial Services Part of McKinsey & Co., Inc., Mckinsey & Co. /Amsterdam/ provides management consultancy services. The company is based in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal Consultant / Advisor | |
| PACIFIC DRILLING S.A. | Contract Drilling | Director/Board Member | |
| Hebei Normal University | College/University | Undergraduate Degree | |
| Columbia Business School | College/University | Masters Business Admin | |
| Rotterdam School of Management | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
| TSAKER NEW ENERGY TECH CO., LIMITED | Industrial Specialties | Corporate Secretary | |
Risun Holding Co. Ltd.
 Risun Holding Co. Ltd. Chemicals: SpecialtyProcess Industries Risun Holding Co. Ltd. is a Chinese chemical company that produces a variety of chemical products including coal tar, benzene, methanol, crude phenol, and industrial naphthalene. The private company is based in Beijing, China. The company was founded in 2004 and the CEO is Feng Shi. | Chemicals: Specialty | General Counsel | |
Swanbridge Capital Management BV
 Swanbridge Capital Management BV Investment ManagersFinance Swanbridge Capital Management is a venture capital firm, headquartered in Netherland. The frim founded in 2016 by Van Herk Investments, the Erasmus Medical Center and the City of Rotterdam. | Investment Managers | Private Equity Investor | |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Bolster Investment Partners BV
 Bolster Investment Partners BV Investment ManagersFinance Bolster Investment Partners BV (Bolster Investment Partners) is an independent private equity firm. The firm was founded by Mark van Rijn, Joost Bakhuizen, Michiel van Wissen and Paul Vogelzang in 1982. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor | |
MiddleGround Management LP
 MiddleGround Management LP Investment ManagersFinance MiddleGround Management LP (MiddleGround Capital) is a private equity firm founded in 2018 by John Stewart and Lauren Mulholland. The firm is headquartered in Lexington, Kentucky. | Investment Managers | Private Equity Investor | |
ABN AMRO Energy Transition
 ABN AMRO Energy Transition Investment ManagersFinance Maas Capital Renewables BV invests in renewable energy projects. It's focus is on late stage and developed projects in North West Europe. The firm provides debt raising, contract structuring, and valuation. The company is headquartered in Rotterdam, the Netherlands. | Investment Managers | Private Equity Analyst | |
Amphista Therapeutics Ltd.
 Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Biotechnology | Director/Board Member | |
| The Bank of Canada (Research Firm) | Investment Managers | Economist | |
| Create Capital Partners B V | Investment Managers | Private Equity Analyst | |
Allero Therapeutics BV
 Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Allero Therapeutics BV is a biopharmaceutical company, which engages in the development of immunotherapies. It focuses on the research and development pipeline with a focus on a celiac disease product and a food allergy product. The company was founded by Poul Sorensen, Emil Pot, Federico Grego, and Kees Leenhouts and is headquartered in Rotterdam, the Netherlands. | Miscellaneous Commercial Services | Chairman | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Gain.pro BV
 Gain.pro BV Packaged SoftwareTechnology Services Gain.pro BV engages in the design, development, and operation of a platform which provides disruptive services to the private equity industry. The firm offers Gain.pro which identifies, screens, and benchmarks businesses for clients. The company was founded by Frister Haveman and Nicola Ebmeyer and is headquartered in Amsterdam, the Netherlands. | Packaged Software | Founder | |
Muna Therapeutics ApS
 Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member | |
Evommune, Inc.
 Evommune, Inc. Miscellaneous Commercial ServicesCommercial Services Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Egle Therapeutics SAS
 Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Director/Board Member | |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| Koala Life Sciences BV | Founder | ||
Sairopa B V
 Sairopa B V MiscellaneousMiscellaneous Sairopa B V is a Dutch company that develops medicines and operates as an investment holding company. | Miscellaneous | Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst |
Statistics
International
| Netherlands | 28 |
| United Kingdom | 7 |
| United States | 6 |
| China | 5 |
| France | 4 |
Sectoral
| Finance | 19 |
| Consumer Services | 16 |
| Health Technology | 6 |
| Commercial Services | 5 |
| Process Industries | 3 |
Operational
| Director/Board Member | 64 |
| Graduate Degree | 51 |
| Private Equity Investor | 37 |
| Corporate Officer/Principal | 32 |
| Undergraduate Degree | 30 |
Most connected contacts
- Stock Market
- Insiders
- Bas Cohen
- Company connections
